Qiagen squeezes into Schuldschein market
Dutch biotechnology firm Qiagen has launched a tightly priced €150m dual currency Schuldschein, with investors treating the Germany-headquartered firm as a domestic issuer.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: